Abstract
Evidence surrounding the benefits of surgical ablation (SA) for atrial fibrillation (AF) at the time of mitral surgery is well established and supported by multiple randomized controlled trials and large observational studies.1 Therefore, the highest level of recommendation supporting its performance was granted by societal guidelines.2,3 In this issue of The Annals of Thoracic Surgery, Mehaffey and colleagues4 from the Virginia Cardiac Surgery Quality Initiative demonstrated that the overall performance and inclusion of SA resembles the current national trends.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
